Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma

doi:10.3748/wjg.v22.i42.9445

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 42

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6972)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

495

WORD

176

HTML

3330

Figures (1-5)

247

Tables (1-1)

221

Sum=4469

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1088

Download

1415

Sum=2503

Nov 14, 2016 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Nov 14, 2016; 22(42): 9445-9450
Published online Nov 14, 2016. doi: 10.3748/wjg.v22.i42.9445

Full Size Figure Download Figure

Figure 3 Two months after sorafenib induction. Computed tomography showed the significantly decrease in size (3 cm) and hypervascularization (A and B, arrow), and portal vein tumor thrombosis remained in the second-order branch of portal vein (C, arrow).

Citation: Takano M, Kokudo T, Miyazaki Y, Kageyama Y, Takahashi A, Amikura K, Sakamoto H. Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma. World J Gastroenterol 2016; 22(42): 9445-9450
URL: https://www.wjgnet.com/1007-9327/full/v22/i42/9445.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i42.9445